apollo
0

About Pacliarc 260 Injection 43.4 ml

Pacliarc 260 Injection 43.4 ml belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. 
 
Pacliarc 260 Injection 43.4 ml contains ‘Paclitaxel’, which works by stopping cell division and preventing the growth of certain cancer cells. 
 
In some cases, Pacliarc 260 Injection 43.4 ml may cause common side effects, such as nausea, vomiting, mild diarrhoea, and joint or muscle pain. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
 
Consult your doctor if you are pregnant, breastfeeding, think you may be pregnant or are planning pregnancy. Pacliarc 260 Injection 43.4 ml is not recommended for children below 18 years. Inform your doctor about your health condition and medications to rule out any side effects.

Uses of Pacliarc 260 Injection 43.4 ml

Ovarian cancer, breast cancer, non-small cell lung cancer.

Medicinal Benefits

Pacliarc 260 Injection 43.4 ml belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Pacliarc 260 Injection 43.4 ml may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Pacliarc 260 Injection 43.4 ml contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells. 

Directions for Use

Pacliarc 260 Injection 43.4 ml will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Pacliarc 260 Injection 43.4 ml

  • Nausea
  • Vomiting
  • Diarrhoea
  • Hair loss
  • Joint or muscle pain
  • Decreased blood cell count

Drug Warnings

Do not take Pacliarc 260 Injection 43.4 ml if you are allergic to any of its components, if your white blood cell or platelet count is very low, if you have a serious uncontrolled infection, and Pacliarc 260 Injection 43.4 ml has to be given for the treatment of Kaposi’s sarcoma (cancer that causes lesions in soft tissues), or if you have severe liver problems. Inform your doctor if you have heart disease, abnormal blood cell counts, irregular heartbeat, tingling, numbness, or burning sensation in fingers or toes, visual problems, if you are on radiation therapy, or if you have Kaposi’s sarcoma and have a sore or inflamed mouth. Also, inform your doctor if you are pregnant, breastfeeding, think you are pregnant or planning pregnancy.

Drug Interactions

Drug-Drug Interactions: Inform your doctor if you are taking antibiotics (rifampicin, erythromycin), anti-fungal (ketoconazole), anti-depressant (fluoxetine), anti-epileptic (carbamazepine, phenytoin), lipid regulating agent (gemfibrozil), antacid (cimetidine), medicines used to treat HIV/AIDS (ritonavir, saquinavir, indinavir, nelfinavir, efavirenz, nevirapine), anti-platelet (clopidogrel).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Inform your doctor if you have a very low white blood cell or platelet count, a serious uncontrolled infection, or severe liver problems.

Drug-Drug Interactions Checker List

  • RIFAMPICIN
  • ERYTHROMYCIN
  • KETOCONAZOLE
  • FLUOXETINE
  • CARBAMAZEPINE
  • PHENYTOIN
  • GEMFIBROZIL
  • CIMETIDINE
  • RITONAVIR
  • SAQUINAVIR
  • INDINAVIR
  • NELFINAVIR
  • EFAVIRENZ
  • NEVIRAPINE
  • CLOPIDOGREL

Habit Forming

No

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, herbs and spices in your diet.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugar.
  • Get optimal sleep; rest well.

Special Advise

  • Your doctor may advise regular blood tests to check for liver activity, kidney function and blood cell count.
  • You and/or your partner should use reliable contraception during treatment with Pacliarc 260 Injection 43.4 ml and for at least six months after the treatment.

Disease/Condition Glossary

Breast cancer: It is a type of cancer that develops in the breast when the breast cells begin to grow abnormally. Symptoms of breast cancer include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.

Ovarian Cancer: Ovarian cancer occurs when abnormal cells grow and multiply in the ovaries and fallopian tubes. Signs and symptoms include pain, swelling, or a feeling of pressure in the pelvis or abdomen, frequent or sudden urge to urinate, feeling full or trouble eating, a lump in the pelvic area, gas, bloating, or constipation.

Non-small cell lung cancer: It is a disease in which cancer cells form in the tissues of the lungs. Smoking is the major risk factor for non-small cell lung cancer. Symptoms include a cough that does not go away and shortness of breath.

Consult Doctor

About Pacliarc 260 Injection 43.4 ml

Pacliarc 260 Injection 43.4 ml belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. 
 
Pacliarc 260 Injection 43.4 ml contains ‘Paclitaxel’, which works by stopping cell division and preventing the growth of certain cancer cells. 
 
In some cases, Pacliarc 260 Injection 43.4 ml may cause common side effects, such as nausea, vomiting, mild diarrhoea, and joint or muscle pain. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
 
Consult your doctor if you are pregnant, breastfeeding, think you may be pregnant or are planning pregnancy. Pacliarc 260 Injection 43.4 ml is not recommended for children below 18 years. Inform your doctor about your health condition and medications to rule out any side effects.

Non returnable*
COD available

Online payment accepted

Composition

PACLITAXEL-260MG

Manufacturer/Marketer

Delarc Pharmaceuticals Pvt Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

for this medicine

Country of origin

India

Manufacturer/Marketer address

Fliar Business Intelligence Private Limited C-32, Arya Samaj Road, Karol Bagh New Delhi, India - 250011
Other Info - PAC0241

FAQs

Pacliarc 260 Injection 43.4 ml works by stopping cell division and preventing the growth of certain cancer cells.

Pacliarc 260 Injection 43.4 ml might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.

The most common side effect of Pacliarc 260 Injection 43.4 ml is hair loss. The hair may grow back after the treatment with Pacliarc 260 Injection 43.4 ml is finished. However, consult your doctor if you have any concerns.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Consult your doctor

It is not known if alcohol interacts with this medicine. Please consult your doctor.

bannner image

Pregnancy

Unsafe

Pacliarc 260 Injection 43.4 ml must not be given during pregnancy unless clearly necessary, as it may cause birth defects. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Pacliarc 260 Injection 43.4 ml.

bannner image

Breast Feeding

Unsafe

Avoid breastfeeding whilst on treatment with Pacliarc 260 Injection 43.4 ml. Do not restart breastfeeding until your doctor tells you it is safe to do so.

bannner image

Driving

Caution

Pacliarc 260 Injection 43.4 ml may cause dizziness, tiredness, or nausea. Drive or operate heavy machinery only if you are alert.

bannner image

Liver

Caution

Do not use Pacliarc 260 Injection 43.4 ml if you have severe liver problems. If you have a history of liver disease, inform your doctor before receiving Pacliarc 260 Injection 43.4 ml.

bannner image

Kidney

Consult your doctor

If you have a history of kidney diseases, inform your doctor before receiving Pacliarc 260 Injection 43.4 ml. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

Pacliarc 260 Injection 43.4 ml is not recommended for children below 18 years due to a lack of data on the safety and effectiveness.

Uses of Pacliarc 260 Injection 43.4 ml

Ovarian cancer, breast cancer, non-small cell lung cancer.

Medicinal Benefits

Pacliarc 260 Injection 43.4 ml belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Pacliarc 260 Injection 43.4 ml may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Pacliarc 260 Injection 43.4 ml contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells. 

Side Effects of Pacliarc 260 Injection 43.4 ml

  • Nausea
  • Vomiting
  • Diarrhoea
  • Hair loss
  • Joint or muscle pain
  • Decreased blood cell count

Directions for Use

Pacliarc 260 Injection 43.4 ml will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Do not take Pacliarc 260 Injection 43.4 ml if you are allergic to any of its components, if your white blood cell or platelet count is very low, if you have a serious uncontrolled infection, and Pacliarc 260 Injection 43.4 ml has to be given for the treatment of Kaposi’s sarcoma (cancer that causes lesions in soft tissues), or if you have severe liver problems. Inform your doctor if you have heart disease, abnormal blood cell counts, irregular heartbeat, tingling, numbness, or burning sensation in fingers or toes, visual problems, if you are on radiation therapy, or if you have Kaposi’s sarcoma and have a sore or inflamed mouth. Also, inform your doctor if you are pregnant, breastfeeding, think you are pregnant or planning pregnancy.

Therapeutic Class

CHEMOTHERAPY

Drug-Drug Interactions

verifiedApollotooltip
PaclitaxelBaricitinib
Severe
PaclitaxelClozapine
Severe

Drug-Drug Interactions

Login/Sign Up

PaclitaxelBaricitinib
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
Coadministration of baricitinib and Pacliarc 260 Injection 43.4 ml can raise the risk of developing serious infections.

How to manage the interaction:
Although there is an interaction, baricitinib can be taken with Pacliarc 260 Injection 43.4 ml if prescribed by the doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning when you urinate, consult a doctor. Do not stop using any medications without talking to a doctor.
PaclitaxelClozapine
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
Combining Pacliarc 260 Injection 43.4 ml with Clozapine can increase the risk of infection.

How to manage the interaction:
Taking Pacliarc 260 Injection 43.4 ml with Clozapine together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, consult the doctor immediately if you experience symptoms such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without first talking to your doctor.
PaclitaxelEtanercept
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
When Etanercept is used with Pacliarc 260 Injection 43.4 ml, the likelihood or severity of infection may increase.

How to manage the interaction:
Although there is a possible interaction between Etanercept and Pacliarc 260 Injection 43.4 ml, you can take these medicines together if prescribed by a doctor. However, if you develop fever, chills, diarrhea, sore throat, muscular pains, shortness of breath, blood in phlegm, weight loss, red or irritated skin, body sores, or discomfort or burning during urination, consult a doctor immediately. Do not discontinue any medications without a doctor's advice.
PaclitaxelInfliximab
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
Combining Infliximab with Pacliarc 260 Injection 43.4 ml can enhance the breakdown of Pacliarc 260 Injection 43.4 ml in the body. This can reduce the treatment outcomes and can increase the risk or severity of developing serious infections.

How to manage the interaction:
Taking Pacliarc 260 Injection 43.4 ml with Infliximab together can result in an interaction, but it can be taken if your doctor has advised it. However, if you experience fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
PaclitaxelThalidomide
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
Taking thalidomide together with Pacliarc 260 Injection 43.4 ml may increase the risk of blood clots and other complications.

How to manage the interaction:
Although taking thalidomide and Pacliarc 260 Injection 43.4 ml together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, consult the doctor immediately if you experience symptoms such as chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, pain, redness or swelling in an arm or leg, and numbness or weakness on one side of the body. Do not discontinue any medications without consulting a doctor.
PaclitaxelCladribine
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
Combining Cladribine with Pacliarc 260 Injection 43.4 ml can increase the risk of developing serious infections.

How to manage the interaction:
Taking Pacliarc 260 Injection 43.4 ml with Cladribine together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
PaclitaxelTofacitinib
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
Taking Tofacitinib with Pacliarc 260 Injection 43.4 ml may increase the risk of infection.

How to manage the interaction:
Although taking Pacliarc 260 Injection 43.4 ml and Tofacitinib together can evidently cause an interaction, it can be taken if your doctor has suggested it. However, consult the doctor immediately if you experience symptoms such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without a doctor's advice.
PaclitaxelRitonavir
Severe
How does the drug interact with Pacliarc 260 Injection 43.4 ml:
Taking Ritonavir and Pacliarc 260 Injection 43.4 ml may significantly increase the blood levels of Pacliarc 260 Injection 43.4 ml.

How to manage the interaction:
Taking Ritonavir with Pacliarc 260 Injection 43.4 ml together can possibly result in an interaction, but it can be taken if your doctor has advised it. In case of any unusual symptoms, consult a doctor. Do not stop using any medications without talking to a doctor.

Drug-Drug Interactions Checker List

  • RIFAMPICIN
  • ERYTHROMYCIN
  • KETOCONAZOLE
  • FLUOXETINE
  • CARBAMAZEPINE
  • PHENYTOIN
  • GEMFIBROZIL
  • CIMETIDINE
  • RITONAVIR
  • SAQUINAVIR
  • INDINAVIR
  • NELFINAVIR
  • EFAVIRENZ
  • NEVIRAPINE
  • CLOPIDOGREL

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, herbs and spices in your diet.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugar.
  • Get optimal sleep; rest well.

Habit Forming

No

Special Advise

  • Your doctor may advise regular blood tests to check for liver activity, kidney function and blood cell count.
  • You and/or your partner should use reliable contraception during treatment with Pacliarc 260 Injection 43.4 ml and for at least six months after the treatment.

Disease/Condition Glossary

Breast cancer: It is a type of cancer that develops in the breast when the breast cells begin to grow abnormally. Symptoms of breast cancer include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.

Ovarian Cancer: Ovarian cancer occurs when abnormal cells grow and multiply in the ovaries and fallopian tubes. Signs and symptoms include pain, swelling, or a feeling of pressure in the pelvis or abdomen, frequent or sudden urge to urinate, feeling full or trouble eating, a lump in the pelvic area, gas, bloating, or constipation.

Non-small cell lung cancer: It is a disease in which cancer cells form in the tissues of the lungs. Smoking is the major risk factor for non-small cell lung cancer. Symptoms include a cough that does not go away and shortness of breath.

Pacliarc 260 Injection 43.4 ml Substitute

Substitutes safety advice
  • Chemotax * 260Mg/43.4Ml Inj

    by AYUR

    179.83per tablet
  • Celtax 260mg/43.3ml Injection 1's

    by Others

    9741.60per tablet
  • CYTAX 260MG INJECTION 43.4ML

    by Others

    199.41per tablet
  • ALTAXEL 260MG INJECTION 43.4ML

    by Others

    199.41per tablet
  • Caitxel 260 mg Injection 43.4 ml

    by Others

    238.37per tablet
whatsapp Floating Button

Add to Cart